Neurogenesis
Neurogenesis is the birth of new neurons. Embryonic neurogenesis — the brain building itself from a sheet of progenitor cells into eighty-six billion neurons before you're born — is settled, uncontroversial, and not what anyone means when they get excited about the word. The excitement, and the controversy, is about adult neurogenesis: the claim that the grown human brain continues to manufacture brand-new neurons throughout life. That claim overturned a dogma that stood for most of the twentieth century, it became a load-bearing pillar of the neuroplasticity gospel, and — this is the part the self-help books leave out — its very existence in the adult human brain is, as of this writing, actively contested by serious labs publishing in the best journals. The honest version of this topic holds two things at once: the rodent evidence is overwhelming, and the human evidence is a knife-fight. Let's pull it all the way down.
What it is, and where the idea came from
For most of the twentieth century, the ruling doctrine was blunt: the adult brain does not make new neurons. You were born with all you'd ever have, and from there it was a slow, one-way drain. The doctrine is usually traced to Santiago Ramón y Cajal, the Spanish anatomist who shared the 1906 Nobel Prize in Physiology or Medicine (with Camillo Golgi) and is regarded as a principal architect of the neuron doctrine. In his Degeneration and Regeneration of the Nervous System (English translation 1928), Cajal wrote a line that became a kind of curse on the field: that in the adult centers "the nerve paths are something fixed, ended, immutable. Everything may die, nothing may be regenerated." He added the hope that future science might one day overturn that verdict — but the field heard only the verdict.
The first serious crack came from a researcher who was, fittingly, largely ignored. Joseph Altman, working at MIT in the 1960s, used a then-new technique — tritiated (³H) thymidine autoradiography, which tags DNA in cells that are actively dividing — and reported newly generated cells in the adult rat brain, including in the hippocampus and the olfactory bulb. His papers from that decade (the 1962 Science report "Are new neurons formed in the brains of adult mammals?", and a series through the mid-1960s, some co-authored with Gopal Das) are now treated as the founding documents of the field. At the time they were treated as a mistake. Dividing cells, the assumption went, must be glia or some other support tissue, not real neurons. Altman lacked the tools to definitively prove the new cells were neurons, the result clashed with Cajal's dogma, and the work was largely buried. He spent much of his later career outside the mainstream of the question he opened.
The idea was revived, with better tools, twice. In the 1980s, Fernando Nottebohm at Rockefeller (with colleagues including Steven Goldman) showed dramatic, functional adult neurogenesis in songbirds — the brain regions controlling song add new neurons, with seasonal turnover linked to song learning, and the new neurons wire into working circuits. This was hard to dismiss: it tied new neurons to a specific learned behavior. But birds were birds, and the mammalian skeptics held the line. Through the 1990s, Elizabeth Gould (then at Rockefeller, later at Princeton) produced a sustained body of work showing adult neurogenesis in rodents and, in a set of papers at the end of the decade, in adult primates — and showing it was modulated by experience and by stress. She took heavy fire for the primate claims; they cut directly against the dogma. (Her most contested claim — adult neurogenesis in primate neocortex, Gould et al. 1999, Science — was specifically challenged by later work, e.g. Kornack & Rakic 2001, and is not considered established; the hippocampal primate findings held up better.)
The watershed for humans came in 1998. Peter Eriksson (a Swedish neurologist) and Fred "Rusty" Gage (at the Salk Institute), with colleagues, published in Nature Medicine a study of human hippocampal tissue. The clever move was opportunistic: certain cancer patients had been given bromodeoxyuridine (BrdU) — a synthetic nucleotide that incorporates into the DNA of dividing cells, used clinically to track tumor growth. BrdU labels any cell born after the injection. When these patients later died and their brains were examined postmortem, the team found BrdU-labeled cells in the dentate gyrus of the hippocampus that also expressed neuronal markers (like NeuN). New neurons, born in adult human brains, caught in the act. That paper is the single most-cited foundation stone for adult human hippocampal neurogenesis, and it more or less ended the argument for two decades. Combined with Gage's later work and the broader plasticity literature, it became textbook fact: yes, the adult human hippocampus makes new neurons.
So the basic claim, in its mature form: in adult mammals, neural stem/progenitor cells in specific niches continue to divide, and a fraction of their daughters mature into functional neurons that integrate into existing circuits. The two best-established niches in rodents are the subgranular zone (SGZ) of the dentate gyrus in the hippocampus, and the subventricular zone (SVZ) lining the lateral ventricles, whose new neurons migrate along the rostral migratory stream to the olfactory bulb. Keep that geography — it matters enormously for the human controversy. Two cautions on porting it to humans: first, the adult human SVZ→olfactory-bulb route appears to be largely absent or vestigial — work such as Sanai et al. (2011, Nature) and the carbon-14 birth-dating of Bergmann et al. (2012) found little evidence of ongoing olfactory-bulb neurogenesis in adult humans, so the human debate centers almost entirely on the hippocampal dentate gyrus, not the olfactory system. Second, even the hippocampal claim is the contested one (see the debates section).
The real science — what the evidence actually shows
The strength of the evidence is wildly uneven across species, and conflating them is the single most common error in popular writing. Separate the tiers.
Rodents: overwhelming and functional. In rats and mice, adult hippocampal neurogenesis is about as well-established as anything in systems neuroscience. We can label the new cells (BrdU, and genetically with reporter mice), watch them mature over weeks, and — the decisive part — manipulate them and measure the behavioral consequence. Ablate adult-born hippocampal neurons (with irradiation, genetic tools, or anti-mitotic drugs) and you produce specific, reproducible deficits — most reliably in pattern separation, the ability to store similar experiences as distinct memories rather than smearing them together. Boost neurogenesis (running wheels, enriched cages) and pattern-separation tasks improve. Modern optogenetics lets researchers silence the young neurons specifically and watch a behavior break. This is not correlational. In rodents, adult-born dentate neurons do a job, and we know roughly what the job is.
Other mammals. Adult hippocampal neurogenesis has been documented in many mammals — though, tellingly, not uniformly. Some species (notably certain bats, and some studies of cetaceans) show little or none, which is itself a clue that the trait is not a fixed mammalian universal but something evolution turns up or down.
Humans: this is where it gets hard, and where the controversy lives. The honest summary is that we cannot do to a living human what we do to a mouse. We cannot inject experimental BrdU into healthy people, we cannot genetically tag their stem cells, and we cannot ablate their new neurons to see what breaks. Every line of human evidence is indirect, and every line has a serious methodological objection. The two cleverest workarounds deserve description because they're the backbone of the "it's real in humans" case:
- *The carbon-14 birth-dating method (Spalding et al., 2013, Cell, from Jonas Frisén's lab). Above-ground nuclear bomb testing from the mid-1950s to 1963 spiked atmospheric carbon-14, which then declined on a known curve after the test-ban treaty. That carbon got into the food chain and into the DNA of every cell at the moment that cell was born. So the ¹⁴C concentration locked into a neuron's DNA is effectively a timestamp of when that neuron's DNA was last synthesized. Frisén's group measured ¹⁴C in DNA from postmortem human hippocampal neurons and concluded that a substantial fraction of dentate gyrus neurons are exchanged throughout adult life — they estimated on the order of ~700 new neurons per day in the adult human hippocampus, with a modest decline with age. This is the strongest quantitative* evidence that the adult human hippocampus keeps making neurons, and it's independent of antibody-staining methods (which is important, given what's coming).
- Immunohistochemistry on postmortem tissue. The more common approach: stain dead human brain tissue for proteins expressed by immature/newborn neurons — doublecortin (DCX), PSA-NCAM, Ki-67 (a proliferation marker), and others — and count the cells. When the tissue is well-preserved and the staining works, several labs report a population of immature-looking neurons in the adult, even elderly, dentate gyrus.
That second method is exactly where the field detonated in 2018 — covered in the debates section below, because it deserves its own treatment.
The mechanism — how it actually works
Strip away the controversy about whether it happens in humans and look at the cellular machinery, which is well-characterized in rodents. New neurons don't appear by magic; they run a multi-week developmental gauntlet, and most of them die.
In the subgranular zone of the dentate gyrus sits a population of radial glia-like neural stem cells (sometimes called Type-1 cells). These are quiescent most of the time. When activated, they divide to produce rapidly proliferating intermediate progenitors, which produce neuroblasts, which begin migrating the short distance into the granule cell layer. Over the following weeks the surviving cells extend dendrites up into the molecular layer and send axons (mossy fibers) toward area CA3, wiring themselves into the existing trisynaptic hippocampal circuit (entorhinal cortex → dentate gyrus → CA3 → CA1).
Three features of this process are load-bearing:
- Massive overproduction and selective survival. The brain makes far more young neurons than it keeps. A large fraction die within the first one to three weeks. Survival is activity-dependent — young neurons that get integrated into active circuits, that participate in learning, live; the rest are pruned. This is why "use it or lose it" is literally true at the cellular level here. Learning a hippocampus-dependent task during the critical survival window rescues new neurons that would otherwise have died.
- A window of hyper-plasticity. For a period of roughly one to several weeks, the immature granule neurons have distinct electrophysiological properties: a lower threshold for long-term potentiation, enhanced excitability, reduced inhibition. During this window they are disproportionately plastic compared to their mature neighbors. This is the leading explanation for why a small number of new neurons can have an outsized functional effect — they're not just extra cells, they're temporarily the most learnable cells in the structure. This maps onto pattern separation: the dentate gyrus's job is to take overlapping inputs and decorrelate them into distinct representations, and a steady supply of fresh, highly-plastic neurons may be what keeps similar memories from collapsing into each other.
- The whole process is exquisitely sensitive to physiology and experience. This is the part that turns a cell-biology fact into a lever.
The drivers (rodent data, mostly):
- Aerobic exercise. Voluntary wheel running is one of the most reliable ways to increase the proliferation and survival of new dentate neurons in rodents. Running roughly doubles the number of new cells in classic studies. The effect is specific to aerobic activity in the cleanest experiments.
- Environmental enrichment. Toys, larger cages, social complexity, novelty — enrichment primarily improves the survival of newborn neurons (whereas running drives proliferation). The two stack.
- Learning itself. Effortful hippocampus-dependent learning during the survival window keeps new neurons alive.
- Antidepressants. Chronic — not acute — treatment with SSRIs (and other classes, plus electroconvulsive therapy, which is among the strongest stimulators) increases hippocampal neurogenesis in rodents. This gave rise to the neurogenesis hypothesis of antidepressant action (Santarelli et al., 2003, Science, from René Hen's lab is the landmark): in mice, blocking hippocampal neurogenesis with focal irradiation abolished the behavioral effects of fluoxetine in some tests. The hypothesis: part of what antidepressants do is restore neurogenesis that chronic stress had suppressed. Note the time course matches the clinical lag — drugs take weeks to work, and new neurons take weeks to mature.
The suppressors:
- Chronic stress and glucocorticoids (cortisol/corticosterone). This is one of the most robust findings in the field. Sustained stress and elevated glucocorticoids reliably suppress hippocampal neurogenesis in rodents. The hippocampus is dense with glucocorticoid receptors, which is part of why it's a stress-target structure. This is the cellular hinge behind the stress–depression link.
- Aging. Neurogenesis declines steeply with age in rodents — the stem cell pool shrinks and goes quiescent. (Whether and how much it declines, or persists, in aged humans is precisely the disputed question.)
- Also: chronic sleep deprivation, chronic inflammation, high alcohol intake, and (in rodents) certain high-fat dietary regimes suppress it.
The molecular common currency: BDNF. Brain-Derived Neurotrophic Factor is the growth factor most consistently implicated in linking all of the above. Exercise raises BDNF; chronic stress lowers it; antidepressants raise it. BDNF supports neuronal survival, dendritic growth, and synaptic plasticity (it's central to LTP, not just neurogenesis). It is not a clean one-to-one switch for neurogenesis — BDNF does many things and the causal arrows are tangled — but it is the molecule that keeps showing up at the intersection of "things that change neurogenesis." Treat it as a major mediator, not a magic dial.
Sharp examples
- The London taxi drivers (Maguire et al., 2000, and follow-ups). Drivers who passed "The Knowledge" — the brutal years-long memorization of London's street layout — had larger posterior hippocampi than controls, and the longer they'd driven, the larger the volume. This is the most-cited human example of experience-driven hippocampal plasticity. Honest caveat: volume change ≠ neurogenesis. Larger hippocampi could reflect dendritic growth, glial changes, or synaptic remodeling rather than new neurons. The study is iconic for plasticity; it is not direct proof of neurogenesis. Pop articles routinely overclaim it. It belongs here precisely because the overclaim is so common.
- Songbirds (Nottebohm). Still the cleanest functional demonstration in any animal: as a canary or zebra finch learns and refines song, new neurons are added to the song-control nucleus HVC and become part of the working circuit, with seasonal turnover. New neurons, tied to a learned behavior, wired in. This is what airtight functional neurogenesis looks like — and it's why the field couldn't keep dismissing the idea.
- The bomb-pulse neurons (Spalding/Frisén, 2013). The fact that you can read a neuron's birthday off Cold-War radioactive carbon trapped in its DNA is one of the most elegant tricks in all of biology, and it's the human evidence hardest to wave away — because it doesn't depend on whether an antibody stained correctly.
- The exercise effect (van Praag, Gage, et al., late 1990s). Running mice growing roughly twice as many new dentate neurons as sedentary mice, with corresponding gains on hippocampal memory tasks, is the experiment that launched a thousand "exercise grows your brain" headlines. The rodent result is real and robust. Whether the magnitude transfers to humans is an inference, not a measurement.
Where it gets distorted — the honest cut
Neurogenesis is catnip for self-help and wellness marketing, and almost every popular treatment commits at least one of these sins:
- Smuggling rodent magnitudes into human bodies. "Running doubles your neurogenesis" is a claim about mice in cages with running wheels. We have no method to measure your personal neurogenesis rate before and after a 5K, and the bomb-pulse data suggest the adult human baseline turnover is modest. Exercise is fantastic for your brain for many well-established reasons (vascular, BDNF, mood, sleep, executive function). "It will double your new-neuron count" is not a claim anyone can verify in you.
- The "grow new brain cells to fix anything" frame. Even where adult neurogenesis is accepted, it is essentially confined to the dentate gyrus (and, in rodents, the olfactory system — the olfactory route looks largely absent in adult humans). It is not a general repair mechanism for the cortex, and it does not regenerate brain after stroke or in neurodegeneration in any therapeutically meaningful, established way. "Neurogenesis" is not a synonym for "the brain heals itself everywhere." Stroke recovery is mostly rewiring of surviving circuits (a different kind of plasticity), not wholesale neuron replacement.
- Conflating neurogenesis with neuroplasticity. This is the big one. Neuroplasticity — synapses strengthening/weakening, dendrites sprouting, circuits remapping — is ubiquitous, lifelong, and the actual engine behind most "rewire your brain" claims. Neurogenesis is a narrow, specific, geographically-confined subset. Most things people credit to "growing new neurons" are actually synaptic plasticity, which doesn't require any new cells at all. The taxi-driver hippocampus is plasticity; people call it neurogenesis.
- Supplement and nootropic hype. "Boost your neurogenesis" is a marketing phrase attached to everything from lion's mane mushroom to curcumin to fish oil. Some of these have preclinical (cell-culture or rodent) signals on neurogenesis or BDNF. None has the kind of controlled human evidence that would justify the confident claims on the label. Preclinical signal is a reason to study something, not a reason to believe the brochure.
- The frequency-blame analog: "your depression is just low neurogenesis, fix it with a jog." The neurogenesis hypothesis of depression is a hypothesis (next section), not established mechanism, and depression is multi-causal. Telling someone their clinical depression is a simple neuron-count deficit they can run off is both scientifically unsupported and potentially cruel.
The throughline of all these distortions: a real, careful, mostly-rodent finding gets inflated into a universal human self-improvement law. The cure is the same as for the Law of Vibration — hold the claim exactly where the evidence holds it, and refuse to let a beautiful mechanism become a magic one.
The debates and the frontier — what's genuinely unresolved
Here is the part most popular treatments will not tell you, because it's inconvenient: whether adult hippocampal neurogenesis meaningfully persists in adult humans is, right now, an open and bitterly contested question. This is not me hedging. In 2018, two high-profile papers published weeks apart (in Nature and Cell Stem Cell) reached nearly opposite conclusions, and the field has not fully reconciled them.
*The case for "it basically stops" — Sorrells et al., 2018 (Nature), from Arturo Álvarez-Buylla's lab at UCSF. This team examined a large set of human hippocampal samples across the lifespan, including carefully-handled tissue, and reported that markers of new neurons (DCX, PSA-NCAM, proliferating cells) dropped sharply in childhood and were essentially undetectable by adulthood.* They found abundant young neurons in infants, a steep decline through childhood, and almost nothing in adults. Their interpretation: adult human hippocampal neurogenesis, if it occurs at all, is so rare as to be functionally negligible — humans are not rodents in this respect, and the earlier consensus may have over-read ambiguous staining. Álvarez-Buylla is one of the most respected stem-cell-niche biologists alive; this was not a fringe paper.
The case for "it persists, even into old age." Two heavyweight responses, also in 2018–2019:
- *Boldrini et al., 2018 (Cell Stem Cell), from Maura Boldrini and colleagues at Columbia.* Using postmortem whole-hippocampus tissue from healthy individuals across the age range, they reported that healthy older adults (into their 70s) retained the ability to generate new neurons — comparable numbers of immature neurons and intermediate progenitors as younger people — even as angiogenesis and the size of the quiescent stem pool declined.
- *Moreno-Jiménez et al., 2019 (Nature Medicine), from María Llorens-Martín's lab in Madrid. They argued the disagreement was largely methodological: that DCX and other immature-neuron markers are extraordinarily sensitive to tissue fixation — how long the brain sat before preservation, the type and duration of fixative. With tightly-controlled, rapidly-processed tissue, they reported thousands of DCX-positive immature neurons in the dentate gyrus of neurologically healthy adults into their 80s* (their oldest healthy subjects were in the late eighties), with the number declining with age and dropping sharply in patients with Alzheimer's disease. Their core charge: the "we found nothing" results may partly reflect degraded tissue and harsh fixation destroying the very epitopes being counted, not the genuine absence of new neurons.
So the live fight has three fronts, and they're worth naming precisely:
- Methodology / fixation. Are negative findings real biology or artifacts of how brains were preserved? DCX staining is genuinely fragile; this is not a trivial objection. But "your antibody failed" is also the kind of unfalsifiable rebuttal that can prop up a dying claim — so the methods question cuts both ways, and that's the point.
- Specificity of markers. Does a DCX-positive cell in an adult human definitely equal a newly born neuron? DCX can be re-expressed or persist in some contexts, and immature-looking morphology isn't proof of recent birth. Skeptics argue the field has sometimes counted "immature-appearing" as "newly born" without nailing the birthdate. The bomb-pulse ¹⁴C method is valuable precisely because it sidesteps this — it dates DNA synthesis directly — though even that method has had its assumptions probed.
- What it would mean functionally even if it persists. Suppose Boldrini and Moreno-Jiménez are right and a few thousand new neurons trickle in per year in adults. Is that enough to matter behaviorally, or is it a vestigial drizzle? In rodents the rate is high enough to do a measurable job; the contested human rates are lower. The functional significance in humans is unestablished regardless of which side wins the existence debate.
The intellectually honest stance as of 2026: the rodent phenomenon is real and functional; the existence and especially the functional importance of the same phenomenon in adult humans is unresolved and actively litigated. Anyone — pop-science or otherwise — who tells you flatly "you grow hundreds of new neurons a day, so do X" is overstating a contested literature. So is anyone who tells you flatly "it's been debunked, adults make none." Both certainties are unearned. The frontier is exactly the seam between them: better birth-dating methods, single-nucleus RNA sequencing to find the molecular signatures of neural progenitors in adult human tissue (recent work has pushed this direction with mixed results), and the hard problem of ever getting a causal handle in a living human brain.
A further open frontier: the neurogenesis hypothesis of depression rests heavily on the assumption that meaningful adult hippocampal neurogenesis exists in humans to be suppressed and restored. If the Sorrells side is broadly right, the human version of that hypothesis weakens considerably — even though the rodent pharmacology is solid. SSRIs plainly work for many people; whether they work partly via neurogenesis in humans is a separate, shakier claim than the rodent literature alone implies. Mark it hypothesis, not mechanism.
How to apply it
Given all the honesty above, what's actually actionable? Quite a lot — if you anchor the actions to the parts of the science that are robust (the inputs and the downstream brain benefits) rather than to the contested output (your personal human neuron count). The behaviors that drive neurogenesis in rodents are, almost without exception, behaviors with independently overwhelming evidence for human brain and mood benefit. You don't need the neurogenesis claim to be settled for the protocol to be worth following. That's the key reframe.
- Train aerobically, regularly. Sustained aerobic exercise is the most reliable neurogenesis driver in animals, and in humans it robustly raises BDNF, improves hippocampal-dependent memory, protects against age-related cognitive decline, improves mood, and is associated with preserved or increased hippocampal volume in older adults (Erickson et al., 2011 is a notable trial showing aerobic exercise increased hippocampal volume in older adults). You cannot measure your neurogenesis; you can bank every other benefit. This is the single highest-leverage move.
- Seek genuine novelty and complexity (environmental enrichment for humans). In rodents, enrichment improves new-neuron survival. The human translation is effortful engagement with novel, complex, socially-rich environments — learning hard new skills, real social connection, changing your routine, travel, instruments, languages. The mechanism in humans is more credibly synaptic plasticity than neurogenesis, but the behavioral prescription is the same and the cognitive-reserve evidence is strong.
- Protect against chronic stress — this is the suppressor side, and it's the most robust lever. Of everything here, the stress/glucocorticoid suppression of neurogenesis is among the best-established findings. Chronic cortisol elevation is bad for the hippocampus through multiple mechanisms (not only neurogenesis — also dendritic atrophy and excitotoxicity). Anything that reliably lowers chronic stress load — sleep, exercise, meditation, social support, actually resolving chronic stressors rather than enduring them — is protecting the structure. Acute stress is fine and even adaptive; the enemy is the chronic, unrelenting kind.
- Prioritize sleep. Chronic sleep deprivation suppresses neurogenesis in animals and independently devastates hippocampal memory consolidation in humans. There's no version of "optimize your brain" that survives chronic short sleep.
- Use learning to "rescue" what you build. The rodent finding that hippocampus-dependent learning during the survival window keeps new neurons alive has a clean behavioral translation: pair physical training with cognitive challenge. Don't just run — run, and then learn something hard. The provocative speculative version (build cells with exercise, recruit them with learning) outruns the human evidence, but the components are individually well-supported and the combination has no downside.
- Mind the suppressors you control. Limit heavy chronic alcohol use; manage chronic inflammation and metabolic health; don't neglect that high chronic stress and poor sleep are the two biggest dials you actually hold.
- Calibrate your beliefs to the evidence — that's an application too. Don't take an SSRI or refuse one based on the neurogenesis hypothesis; that's a clinical decision on clinical grounds. Don't buy the "boosts neurogenesis" supplement on the strength of a mouse study. The discipline of holding a contested finding at its true confidence level is the master skill here, and it generalizes far beyond this one topic.
The clean summary of the application: do the inputs that have overwhelming independent evidence, treat the human neurogenesis output as a contested bonus, and never let a marketer or a self-help author collapse the distinction.
Connects to
The Law of Perpetual Transmutation is the natural home for this concept. That Hermetic law says energy is in ceaseless motion and is always being transmuted from one form to another — nothing in the universe is static; everything is endlessly becoming. Neurogenesis is that law written into your own skull. The deepest old dogma about the brain was a Cajal-era denial of perpetual transmutation — the claim that the adult brain is "fixed, ended, immutable," a finished structure quietly decaying. Adult neurogenesis (and the broader neuroplasticity it sits inside) is the empirical overturning of that stasis: the substrate of your mind is not a frozen artifact but a system in continuous turnover, building, pruning, and rebuilding itself. The honest nuance the law respects, though, is that transmutation here is bounded and regional — it is not unlimited, not everywhere, and in humans not even fully confirmed. That's the law in its mature form rather than its magical one: the brain is always in motion, but you don't get infinite motion, and you don't get to fake the motion you didn't earn through the inputs.
- Neuroplasticity — the larger, lifelong, ubiquitous phenomenon (synaptic and structural remodeling) that neurogenesis is a narrow, special-case subset of. Most "rewire your brain" claims are really plasticity, not neurogenesis. Doidge's The Brain That Changes Itself popularized the plasticity story.
- The hippocampus and dentate gyrus — the structure and substructure at the center of the whole topic; also the brain's memory-encoding and stress-target organ, which is why stress, memory, and neurogenesis braid together here.
- BDNF — the molecular common currency linking exercise, stress, and antidepressants to neuronal survival and plasticity.
- The HPA axis / cortisol — the stress machinery whose chronic over-activation is the most robust suppressor of neurogenesis (connects to Sapolsky's work on glucocorticoids and the hippocampus, Why Zebras Don't Get Ulcers).
- Pattern separation and memory — the leading candidate function of adult-born hippocampal neurons in rodents.
- The Law of Cause & Effect — the corrective against magical-literalist neurogenesis: new neurons (if they come) come from real causes — movement, learning, recovery — not from wishing for them.
- Thinkers: Santiago Ramón y Cajal (the dogma) · Joseph Altman (the ignored founder, 1960s) · Fernando Nottebohm (songbirds) · Elizabeth Gould (primates, stress) · Fred Gage & Peter Eriksson (human BrdU, 1998) · Jonas Frisén (¹⁴C bomb-pulse dating) · René Hen (neurogenesis–antidepressant hypothesis) · Arturo Álvarez-Buylla / Sorrells (the 2018 skeptical case) · Maura Boldrini & María Llorens-Martín / Moreno-Jiménez (the 2018–2019 "it persists" case).
The adult brain can grow new neurons — definitely in mice, in one tiny region, where it does real work; arguably in you, where the evidence is a live fistfight. Train, learn hard, sleep, and dethrone chronic stress: the inputs are proven even where the output is still in dispute.